Reporter Joe Lynam covers AstraZeneca & Pfizer deal and speaks with Richard Mason, CEO of XO1 Ltd and a fellow in Health Management at Cambridge Judge Business School. Richard discusses what role Cambridge plays in new drugs development. Listen from about 2 hrs 11 mins.
Listen to the podcast [bbc.co.uk]
Brain food 
Compass 
Entrepreneurship 
In the media 
Network 
News 
Reasons why 
The lowdown 
Thinkers
Comments